Phase 1 Advanced Solid Cancer Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

Advanced Solid CancerKRAS G12D Mutation

Arvinas Inc.159 enrolled14 locationsNCT07023731

Recruiting

Phase 1

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Breast CancerOvarian CancerProstate Cancer+4 more

Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd30 enrolled2 locationsNCT06666270

Recruiting

Phase 1

APG-2449 in Patients With Advanced Solid Tumors

Advanced Solid Cancer

Ascentage Pharma Group Inc.165 enrolled9 locationsNCT03917043